文献速递糖尿病肥胖与代谢综合征

2型糖尿病分区多基因评分与454,193名个体13个队列中疾病结局的相关性

Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 Individuals Across 13 Cohorts.
PubMed 文献 · Diabetes Care · 2022-01-01

基于CHARGE联盟12项研究和UK Biobank共454,193名个体,构建5个T2D基因簇的分区多基因评分(pPS),检验其与血压、肾功能、胰岛素使用、T2D诊断年龄及冠状动脉疾病(CAD)的横断面关联。各簇pPS均含T2D风险增加等位基因,但与代谢结局关联不同:肥胖和脂肪营养不良簇pPS均与血压升高和高血压显著相关;脂肪营养不良簇pPS与CAD正相关而肝脏/脂质簇pPS与CAD负相关;肝脏/脂质簇pPS升高还与肾功能降低显著相关。结论支持遗传驱动的T2D通路对临床结局有不同易感性。

要点

  • 肥胖和脂肪营养不良簇pPS均与血压升高和高血压显著相关。
  • 脂肪营养不良簇pPS与CAD正相关,肝脏/脂质簇pPS与CAD负相关。
  • 肝脏/脂质簇pPS升高与肾功能降低显著相关。

核心结论

  • 遗传驱动的T2D通路对临床结局有不同易感性。

研究设计与样本

  • 在CHARGE联盟12项研究和UK Biobank共454,193名个体中构建5个T2D基因簇的分区多基因评分(pPS),横断面检验与T2D相关结局的关联。

主要发现

  • 肥胖和脂肪营养不良簇pPS与肥胖指标关联方向相反,但均与血压升高和高血压显著相关。
  • 脂肪营养不良簇pPS与CAD正相关,肝脏/脂质簇pPS与CAD负相关。
  • 肝脏/脂质簇pPS升高与肾功能降低显著相关。
  • 肝脏/脂质簇包含GCKR、PNPLA3和TM6SF2等与肝脏脂质代谢相关的已知位点。

关键数值与推荐

  • 五个基因簇分别为β细胞、胰岛素原、肥胖、脂肪营养不良和肝脏/脂质簇。
  • 所有簇均含T2D风险增加等位基因。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type 2 diabetes (T2D) has heterogeneous patient clinical characteristics and outcomes. In previous work, we investigated the genetic basis of this heterogeneity by clustering 94 T2D genetic loci using their associations with 47 diabetes-related traits and identified five clusters, termed β-cell, proinsulin, obesity, lipodystrophy, and liver/lipid. The relationship between these clusters and individual-level metabolic disease outcomes has not been assessed. RESEARCH DESIGN AND METHODS: Here we constructed individual-level partitioned polygenic scores (pPS) for these five clusters in 12 studies from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium and the UK Biobank (n = 454,193) and tested for cross-sectional association with T2D-related outcomes, including blood pressure, renal function, insulin use, age at T2D diagnosis, and coronary artery disease (CAD). RESULTS: Despite all clusters containing T2D risk-increasing alleles, they had differential associations with metabolic outcomes. Increased obesity and lipodystrophy cluster pPS, which had opposite directions of association with measures of adiposity, were both significantly associated with increased blood pressure and hypertension. The lipodystrophy and liver/lipid cluster pPS were each associated with CAD, with increasing and decreasing effects, respectively. An increased liver/lipid cluster pPS was also significantly associated with reduced renal function. The liver/lipid cluster includes known loci linked to liver lipid metabolism (e.g., GCKR, PNPLA3, and TM6SF2), and these findings suggest that cardiovascular disease risk and renal function may be impacted by these loci through their shared disease pathway. CONCLUSIONS: Our findings support that genetically driven pathways leading to T2D also predispose differentially to clinical outcomes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. DiCorpo D, LeClair J, Cole JB, et al. Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 Individuals Across 13 Cohorts. Diabetes Care. 2022. PMID: 35085396. doi:10.2337/dc21-1395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。